Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. (SHE:300937)

SHE:300937 Revenue

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical had revenue of 1.11B CNY in the quarter ending March 31, 2026, a decrease of -2.08%. This brings the company's revenue in the last twelve months to 4.43B, up 3.16% year-over-year. In the year 2025, Sichuan Hezong Medicine Easy-to-buy Pharmaceutical had annual revenue of 4.45B with 1.67% growth.

• Revenue (ttm): 4.43B
• Revenue Growth: +3.16%
• P/S Ratio: 0.50
• Revenue / Employee: 3.79M
• Employees: 1,170
• Market Cap: 2.23B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.45B	73.19M	1.67%
Dec 31, 2024	4.38B	-49.60M	-1.12%
Dec 31, 2023	4.43B	461.21M	11.62%
Jan 1, 2023	3.97B	568.62M	16.72%
Jan 1, 2022	3.40B	610.45M	21.88%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 31, 2026

Data Sources Report a data error